Production and Characterization of Monoclonal Antibodies against Human Ceruloplasmin

  • Eum, Won-Sik ;
  • Choi, Hee-Soon ;
  • Kim, Dae-Won ;
  • Jang, Sang-Ho ;
  • Choi, Soo-Hyun ;
  • Kim, So-Young ;
  • Park, Jin-Seu ;
  • Kang, Jung-Hoon ;
  • Cho, Sung-Woo ;
  • Kwon, Oh-Shin ;
  • Hwang, In-Koo ;
  • Yoo, Ki-Yeon ;
  • Kang, Tae-Cheon ;
  • Won, Moo-Ho ;
  • Choi, Soo-Young
  • Published : 2005.01.31


Ceruloplasmin (CP) is the major plasma antioxidant and copper transport protein. Monoclonal antibodies (mAbs) against human CP were produced and characterized. A total of five hybridoma cell lines were established (CP2, CP10, CP20, CP25, CP30). From the epitope mapping analysis, two subgroups of mAbs recognize different peptide fragments were identified. When the purified CP was incubated with the mAbs, the ferroxidase activity of CP was inhibited up to a maximum 57%. Immunoblotting with various tissue homogenates indicated that all the mAbs specifically recognize a single protein band of 130 kDa. They also appear to be extensively cross-reactive among different mammalian including human and avian sources. These results demonstrated that only one type of immunologically similar CP is present in all of the mammalian tissues including human. The CP mAbs could be of great benefit to design the diagnostic kit for CP-related diseases such as Wilson's disease.


Antioxidants;Human ceruloplasmin;Monoclonal antibodies


  1. Choi, E. Y., Jang, S. H. and Choi, S. Y. (1996) Human brain GABA transaminase is immunologically distinct from those of other mammalian brain. Neurochem. Int. 28, 597-600
  2. Gitlin, J. D. (1988) Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263, 6281-6287
  3. Irigoyen Oyarzabal, A. M., Amiguet Garicia, J. A., Lopez Vivaco, G., Genolla Subirats, J., Munoz Villafranca, M. C., Ojembarrena Martinez, E. and Liso Irurzun, P. (2003) Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer. Gastroenterol. Hepatol. 26, 624-629
  4. Ozyilkan, O., Baltali, E. and Kirazli, S. (2000) CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer. East Afr. Med. J. 77, 291-294
  5. Nayak, S. B., Bhat, V. R., Upadhyay, D. and Udupa, S. L. (2003) Copper and ceruloplasmin status in serum of prostate and colon cancer patients. Indian J. Physiol. Pharmacol. 47, 108- 110
  6. Fleming, R. E. and Gitlin, J. D. (1990) Primary structure of rat ceruloplasmin and analysis of tissue-specific gene expression during development. J. Biol. Chem. 265, 7701-7707
  7. Fleming, R. E., Whitman, I. P. and Gitlin, J. D. (1991) Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxida. Am. J. Physiol. 260, 68-74
  8. Lee, H. Y., Eum, W. S., Kim, D. W., Lee, B. R., Yoon, C. S., Jang, S. H., Choi, H. S., Choi, S. H., Back, N.-I., Kang, J. H., Kang, T.-C., Won, M. H., Cho, S.-W., Lee, K. S., Park, J. and Choi, S. Y. (2003) Isolation and identification of antioxidant enzyme catalase stimulatory compound from Garnoderma lucidum. J. Biochem. Mol. Biol. 36, 450-455
  9. Shulman, H., Wilde, C. D. and Kohler, G. (1978) A better cell line for making hybridomas secreting specific antibodies, Nature 276, 269-270
  10. Sunderman, F. W. Jr. and Nomoto, S. (1970) Measurement of human serum ceruloplasmin by its p-phenylenediamine oxidase activity. Clin. Chem. 16, 903-910
  11. Danks, D. M. (1989) Disorders of copper transport; in The Metabolic Basis of Inheritd Disease, Scrier, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.), pp. 1411-1431, McGraw Hill, New York, USA
  12. Osaki, S., Johnson, D. A. and Frieden, E. (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241, 2746-2751
  13. Aouffen, M., Paquin, J., De Grandpre, E., Nadeau, R. and Mateescu, M. A. (2001) Deglycosylated ceruloplasmin maintains its enzymatic, antioxidant, cardioprotective, and neuroprotective properties. Biochem. Cell Biol. 79, 489-497
  14. Choi, E. Y., Park, S. Y., Jang, S. H., Song, M. S., Cho, S. W. and Choi, S. Y. (1995) Production and characterization of monoclonal antibodies to bovine brain succinic semialdehyde reductase. J. Neurochem. 64, 371-377
  15. Culotta, V. C. and Gitlin, J. D. (2001) Disorders of copper transport; in The Metabolic Basis of Inheritd Disease, Scrier, C. R., Beaudet, A. L., Sly, W. S. and Valle, D. (eds.), pp. 3105-3126, McGraw Hill, New York, USA
  16. Richardson, D. R. (1999) Role of ceruloplasmin and ascorbate in cellular iron release. J. Lab. Clin. Med. 13, 454-465
  17. Kang, J. H., Kim, K. S., Choi, S. Y., Kwon, H. Y., Won, M. H. and Kang, T. C. (2002) Protection by carnosine-related dipeptides against hydrogen peroxide-mediated ceruloplasmin modification. Mol. Cells 13, 107-112
  18. Scheinberg, I. H. and Steinlieb, I. (1984) Ceruloplasmin; in Wilson Disease, Lloyd, H. and Smith, Jr. (eds.), pp. 1-171, W. B. Saunders Co., Philadelphia, USA
  19. Choi, S. Y., Kwon, H. Y., Kwon, O. B., Eum, W. S. and Kang, J. H. (2000) Fragmentation of human ceruloplasmin induced by hydrogen peroxide. Biochimie 82, 175-180
  20. Lee, Y. and Song, K. B. (2002) Effects of $\gamma$-irradiation on the molecular properties of myoglobin. J. Biochem. Mol. Biol. 35, 590-594
  21. Eum, W. S. and Kang, J. H. (1999) Release of copper ions from the familial amyotrophic lateral sclerosis-associated Cu,Znsuperoxide dismutase mutants. Mol. Cells 9, 110-114
  22. Mateescu, M. A., Chahine, R., Roger, S., Atanasiu, R., Yamaguchi, N., Nalumiere, G. and Nadeau, R. (1995) Protection of myocardial tissue against deleterious effects of oxygen free radicals by ceruloplasmin. Arzneim.-Forsch. 45, 476-480
  23. Swain, J. A., Darley-Usmar, V. and Gutteridge, J. M. (1994) Peroxynitrite release copper from ceruloplasmin: implications for atherosclerosis. FEBS Lett. 342, 49-52